SCHEMBL331445

SCHEMBL331445

OCCOCCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3857612 0.88
SCHEMBL11898007 0.84
SCHEMBL92157 0.84
SCHEMBL10385079 0.84
SCHEMBL1802846 0.81 MEN1 (0.73)
SCHEMBL2373680 0.81 MEN1 (0.73)
SCHEMBL29300048 0.81 MEN1 (0.37)
SCHEMBL295730 0.81 TSHR (0.77)
SCHEMBL651261 0.81 TSHR (0.77)
SCHEMBL10937926 0.81 TSHR (0.77)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116143982-A Novel pure polyurea waterproof material suitable for different climate changes and preparation process thereof 四川童燊防水工程有限公司 2023-05-23 CN claimed
CN-116143982-A Novel pure polyurea waterproof material suitable for different climate changes and preparation process thereof 四川童燊防水工程有限公司 2023-05-23 CN disclosed
US-20230132386-A9 GRANZYME B DIRECTED IMAGING AND THERAPY CYTOSITE BIOPHARMA INC. 2023-04-27 US disclosed
US-20230132386-A9 GRANZYME B DIRECTED IMAGING AND THERAPY CYTOSITE BIOPHARMA INC. 2023-04-27 US disclosed
US-20220135593-A1 GRANZYME B DIRECTED IMAGING AND THERAPY CYTOSITE BIOPHARMA INC (US) 2022-05-05 US disclosed
CN-107207753-A Hard-coated film, polarizer, the manufacture method of liquid crystal display device and hard-coated film 富士胶片株式会社 2017-09-26 CN disclosed
CN-101104704-B Composition curable with actinic energy ray and use thereof NATOCO CO LTD 2013-04-17 CN disclosed
US-8097621-B2 Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors PFIZER INC. (US) 2012-01-17 US disclosed
US-8097621-B2 Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors PFIZER INC. (US) 2012-01-17 US disclosed
US-7887790-B2 Polymers and polymer coatings CORNELL RESEARCH FOUNDATION, INC. (US) 2011-02-15 US disclosed
US-20070272825-A1 Composition to Reduce Adhesion Between a Conformable Region and a Mold MOLECULAR IMPRINTS, INC. (US) 2007-11-29 US disclosed
CN-1279108-C Low refractivity material and antireflecting film NIPPON OILS & FATS CO LTD (JP) 2006-10-11 CN disclosed
EP-1689751-A1 5,7-DIAMINOPYRAZOLO¬4,3-D|PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY Pfizer Limited (GB) 2006-08-16 EP disclosed
CN-1703435-A Actinic ray-curable composition and use thereof NATOCO CO LTD (JP) 2005-11-30 CN disclosed
US-20050245544-A1 Novel pharmaceuticals AMPLIFIED PROTEOMICS INC. 2005-11-03 US disclosed
WO-2005049616-A1 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY PFIZER LIMITED (GB) 2005-06-02 WO disclosed
WO-2005049616-A1 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY PFIZER LIMITED (GB) 2005-06-02 WO disclosed
CN-1117726-C Fluorine-containing polyfunctional (meth) acrylate and fluorine-containing monomer composition NIPPON OILS & FATS CO LTD (JP) 2003-08-13 CN disclosed
CN-1410484-A Low refractivity material and antireflecting film NIPPON OILS & FATS CO LTD (JP) 2003-04-16 CN disclosed
CN-1189149-A Fluorine-containing polyfunctional (meth) acrylate, fluorine-containing monomer composition, low refractive index material, and antireflection film NIPPON OILS & FATS CO LTD (JP) 1998-07-29 CN disclosed